Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on (S) 1 (2,6 dichloro 3 fluoro phenyl) ethanol. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN105294401A reveals high-ee synthesis route. Reduces catalyst cost significantly. Reliable supplier for pharmaceutical intermediates ensuring supply chain continuity.
Patent CN106047950A details enzymatic reduction for high-purity intermediates. Offers cost reduction and scalable supply chain solutions for global pharmaceutical manufacturing.
Patent CN108285908B reveals a green enzymatic route for (S)-1-(2,6-dichloro-3-fluoro-phenyl) ethanol, offering superior purity and cost efficiency for API manufacturing.
Patent CN107794282B reveals a high-yield biocatalytic route for Crizotinib intermediates using Geotrichum candidum, offering superior purity and cost efficiency for API manufacturing.